Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
IRCT20100524004010N23 - Heyndrickxia coagulans GBI-30 - 6086 + Inulin-type fructans (ITF) / Inulin & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) is a randomized, double-blind, placebo-controlled clinical trial studying Heyndrickxia coagulans GBI-30 - 6086 + Inulin-type fructans (ITF) / Inulin or placebo in fifty three randomized patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) (1)
Reduction in steatosis score in Fibroscan exam (1)
At the con…